Immunotherapy in the Management of Lung Cancer

Immunotherapy in the Management of Lung Cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Бібліографічні деталі
Автор:	Tasnim, Humayra
Інші автори:	khan, Tanisha Tabassum Sayka
Формат:	Дисертація
Мова:	en_US
Опубліковано:	Brac University 2022
Предмети:	Lung cancer Immunotherapy Cytokines Checkpoint inhibitors Adoptive cell therapy Vaccines Cancer > Treatment Cancer > Immunotherapy
Онлайн доступ:	http://hdl.handle.net/10361/17515

Схожі ресурси

Current practice and approaches of immunotherapy in Cancer treatment
за авторством: Khondokar, Faiza
Опубліковано: (2022)

A review on targeted therapies for lung cancer
за авторством: Ashraf, Anushey
Опубліковано: (2023)

Immunotherapy in the treatment of renal cancer
за авторством: Shimu, Sumaya
Опубліковано: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
за авторством: Ratu, Tabassum
Опубліковано: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
за авторством: Fred, Namanda Rogers
Опубліковано: (2021)

A review paper on Nanotechnology based strategies in the treatment of cancer
за авторством: Rahman, Samia
Опубліковано: (2022)

CAR-T cell Therapy in B-cell Lymphoma
за авторством: Faruk, Asef
Опубліковано: (2020)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
за авторством: Flora, Sanzida Alam
Опубліковано: (2024)

Dendritic cell vaccine for the treatment of cancer
за авторством: Haque, Tanzila
Опубліковано: (2023)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
за авторством: Abir, Shifaty Nur
Опубліковано: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
за авторством: Bristy, Israt Zerin
Опубліковано: (2021)

Role of toll-like receptors in cancer immunotherapy– a review
за авторством: Khan, Rezia Nowrin
Опубліковано: (2021)

Stem cell in cancer disease cure vs cause
за авторством: Chowdhury, Marisha Mansur
Опубліковано: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
за авторством: Jahan, Nusrat
Опубліковано: (2024)

Molecules associated with the development of lung cancer
за авторством: Rahman, Adree, та інші
Опубліковано: (2023)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
за авторством: Rahman, Sanjida
Опубліковано: (2024)

Potential of liposomes for the treatment of lung cancer- a review
за авторством: Mim, Shanzida
Опубліковано: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
за авторством: Rahman, Tasnim
Опубліковано: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
за авторством: Tania, Umme
Опубліковано: (2023)

A review on recent advances in drugs for lung cancer treatment
за авторством: Noor, Fouzia
Опубліковано: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
за авторством: Jeba, Joynob
Опубліковано: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
за авторством: Razna, Amrin Islam
Опубліковано: (2019)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
за авторством: Meem, Manila
Опубліковано: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
за авторством: Islam, Saidul
Опубліковано: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
за авторством: Pial, Sazia Afrin
Опубліковано: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
за авторством: Paul, Pulock
Опубліковано: (2024)

Stem cells as therapeutic carrier in cancer treatment
за авторством: Anika, Mysha Yeasmin
Опубліковано: (2022)

Recent advances in Cancer treatment targeting autophagy and future aspects
за авторством: Emon, Kamrul Hasan
Опубліковано: (2022)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
за авторством: Shabnam, Musharrat
Опубліковано: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
за авторством: Zangmo, Thinley
Опубліковано: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
за авторством: Hoque, Ismoth Ara
Опубліковано: (2024)

A comprehensive review on drug repurposing in cancer treatment
за авторством: Sarkar, Onusree
Опубліковано: (2024)

Lung cancer detection and classification using machine learning
за авторством: Arefin, Mahbubul, та інші
Опубліковано: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
за авторством: Nandy, Aditi
Опубліковано: (2022)

Targeted therapeutic options in the treatment of Breast Cancer
за авторством: Alam, Kazi Tasnuva
Опубліковано: (2022)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
за авторством: Pecorino, Lauren
Опубліковано: (2012)

Statistics and informatics in molecular cancer research

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
за авторством: Khan, Muidul Hasan
Опубліковано: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
за авторством: Kamal, Tasnova
Опубліковано: (2019)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
за авторством: Hasan, Amit
Опубліковано: (2024)